Results for Mitochondrial Dysfunction

Marni Falk, MD, and Adam Resnick, PhD, to lead the Mitochondria and Cancer Connections (MC²) Research Program, a new CHOP research initiative.

Xilma Ortiz-Gonzalez, MD, PhD, a neurogeneticist early in her career, receives a Burroughs Wellcome Fund Career in Medical Sciences Award.

New preclinical findings from extensive cell and animal studies suggest that a drug already used for a rare kidney disease could benefit patients with some mitochondrial disorders—complex conditions with severe energy deficiency for which no proven effective treatments exist. Future clinical research is needed to explore whether the drug, cysteamine bitartrate, will meaningfully benefit patients.

In Newly Recognized Cause of a Pediatric Mitochondrial Disease, CHOP Researchers Find Long-awaited Answers for Parents

CHOP Researchers Co-Author Expert Review of Nutritional Interventions

From new insights into brain tumor biology to building a network for pediatric trials, don't miss this week's research roundup.